Cargando…
ROS-mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC
Deoxyribonucleic acid (DNA) epigenetic modification has been linked to specific sequences of CpG islands and plays roles in the progression of lung cancer. In this study, it was found that peroxiredoxin-5 (PRDX5) was highly expressed in non-small cell lung cancer (NSCLC) tissues; however, its specif...
Autores principales: | Cao, Xiang, Chen, Xin-Ming, Xiao, Wei-Zhang, Li, Ben, Zhang, Bo, Wu, Qiong, Xue, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797423/ https://www.ncbi.nlm.nih.gov/pubmed/33416106 http://dx.doi.org/10.3892/ijmm.2020.4819 |
Ejemplares similares
-
PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress
por: Chen, Xinming, et al.
Publicado: (2020) -
PRDX1 and MTH1 cooperate to prevent ROS-mediated inhibition of telomerase
por: Ahmed, Wareed, et al.
Publicado: (2018) -
Peroxiredoxin V (PrdxV) negatively regulates EGFR/Stat3-mediated fibrogenesis via a Cys48-dependent interaction between PrdxV and Stat3
por: Choi, Hoon-In, et al.
Publicado: (2019) -
Porcine Picornavirus 3C Protease Degrades PRDX6 to Impair PRDX6-mediated Antiviral Function
por: Wang, Congcong, et al.
Publicado: (2021) -
PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC
por: Ji, Lili, et al.
Publicado: (2019)